Renalytix (Reg S) (RENX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

5.85p
   
  • Change Today:
    -0.30p
  • 52 Week High: 9.60
  • 52 Week Low: 1.73
  • Currency: UK Pounds
  • Shares Issued: 494.75m
  • Volume: 670,353
  • Market Cap: £28.94m
  • RiskGrade: 348

RENX Overview

RenalytixAI is a developer of artificial intelligence (AI) enabled clinical decision support solutions for kidney disease, one of the most common and costly chronic medical conditions globally. RenalytixAI’s solutions are being designed to make significant improvements in kidney disease risk assessment, clinical care and patient stratification for drug clinical trials.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -1293.5% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 6.6 n/a
Pr/Book n/a  
Latest F'cast
Revenue -32.7% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

RENX Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-20 n/a (10.61) (16.00)¢ n/a n/a n/a n/a 0.0%
30-Jun-21 1.49 (35.79) (43.00)¢ n/a n/a n/a n/a 0.0%
30-Jun-22 2.97 (49.63) (78.00)¢ n/a n/a n/a n/a 0.0%
30-Jun-23 3.40 (45.60) (55.00)p n/a n/a n/a n/a 0.0%
30-Jun-24 2.29 (33.45) (31.00)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

RENX Company Announcements

Result of GM 28-Sep-2026 12:43 RNS
Directorate change 28-Sep-2026 07:00 RNS
Holding(s) in Company 16-Sep-2026 14:13 RNS

RENX ShareCast News

Holding(s) in Company 24-Dec-2025 ShareCast
Holding(s) in Company 23-Dec-2025 ShareCast
Holding(s) in Company 19-Dec-2025 ShareCast

Latest RENX Director Deals

Traded Action Notifier PriceAmountValue
15-Sep-26 Buy James Renwick McCullough 309.41p 250 £773.52
11-Sep-26 Buy James Renwick McCullough 326.75p 250 £816.87
09-Sep-26 Buy James Renwick McCullough 292.30p 90 £263.07

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

RENX Market Data

Currency UK Pounds
Share Price 5.85p
Change Today -0.30p
% Change -4.88 %
52 Week High 9.60
52 Week Low 1.73
Volume 670,353
Shares Issued 494.75m
Market Cap £28.94m
RiskGrade 348

RENX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend Not Available
Income Not Available
Growth Not Available

RENX Dividends

No dividends found

Trades for 29-Sep-2026

Time Volume / Share Price
10:22 4,333 @ 5.75p
08:55 50,000 @ 5.83p
08:55 100,000 @ 5.80p
08:54 100,000 @ 5.80p
08:52 20,497 @ 5.83p

RENX Key Personnel

CEO James Renwick McCullough

Top of Page